Yoga for Painful Chemotherapy-Induced Peripheral Neuropathy: A Pilot, Randomized-Controlled Study

Yoga for Painful Chemotherapy-Induced Peripheral Neuropathy: A Pilot, Randomized-Controlled Study

This research study will examine the feasibility of conducting an eight-week yoga intervention for individuals with chronic painful chemotherapy-induced peripheral neuropathy.

This research study will examine the feasibility of conducting an eight-week yoga intervention for individuals with chronic painful chemotherapy-induced peripheral neuropathy. The investigators will also explore participants' perceptions of acceptability and satisfaction with the yoga intervention. Lastly, the investigators will examine changes in chemotherapy-induced peripheral neuropathy severity, physical function, sleep-related impairment, fatigue, anxiety, depression, and pain following the eight-week yoga intervention.

Inclusion Criteria:

-≥18 years of age,

• self-report ≥ 4/10 worst chemotherapy-induced peripheral neuropathy pain over the past week,
• at least three months post neurotoxic chemotherapy completion
• signed informed consent,
• willingness to participate in all study activities
• speak/read English

Exclusion Criteria:

• prognosis of less than three months,
• documented peripheral neuropathy due to other causes (e.g., diabetes),
• planned receipt of neurotoxic chemotherapy during the study period,
• practice yoga >45 minutes per week over the past six months,
• diagnosis or documented recent history of significant psychiatric comorbidity (i.e., psychosis, suicidal ideation, or substance abuse)
• clinician deems that the patient is physically/functionally unable to participate in a yoga program